A study on the price of midostaurin in the Indian market

Midostaurin (Midostaurin) is a drug widely used to treat specific types of blood cell cancers (such as acute myeloid leukemia AML and mast cell leukemia MCL) and immune system diseases (such as mastocytosis). Its main mechanism of action is by inhibiting or blocking the growth of cancer cells and certain immune cells (mast cells).

Patients should read the drug instructions carefully before using midostaurin and each time they purchase the drug, and take the medication strictly in accordance with the doctor's instructions. Typically, this medication is taken by mouth with food, twice daily, 12 hours apart. Patients should swallow the capsule whole when taking it to avoid damaging the capsule shell. Specific dosages will be adjusted based on the patient's specific medical condition and response to treatment. In certain circumstances, patients may not need to continue taking the medication every day (for example, some patients may need to adopt a "2 weeks on, 2 weeks off" medication regimen). In addition, doctors may prescribe other medications to prevent nausea and vomiting, and patients should take them strictly as directed.

In India, Midostaurin has both original and generic versions on the market. These drugs are roughly the same in terms of ingredients, efficacy and specifications, but have slightly different manufacturers and prices. The original Indian version of Midostaurin produced by Novartis is packaged in a package of 25mg*112 pills and costs about RMB 17,000 (the price may change due to exchange rate fluctuations). As for the Indian generic version of midostaurin, the common manufacturer is BDR Pharmaceuticals, and the price of the same specifications is about more than 9,000 yuan (the price may change due to exchange rate fluctuations). When purchasing, patients should choose a suitable version of the drug based on their financial situation and doctor's recommendations.